RepliCel Life Sciences Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced net loss was CAD 1.048 million compared to CAD 349,338 a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.01 a year ago. For the half year, net loss was CAD 2.404 million compared to CAD 724,454 a year ago. Basic loss per share from continuing operations was CAD 0.08 compared to CAD 0.02 a year ago.